LMW-HA/Lyve-1 interaction is therefore a two-edged sword for tumors such as melanoma as on the one hand it promotes lymphangiogenesis and therefore lymphangiogenic metastasis; on the other hand it inhibits LMW-HA dependent melanoma cell proliferation. Here, LYVE1 is linked to melanoma.